-
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Rating of "Moderate Buy" from Brokerages
ソース: Buzz FX / 18 3 2025 02:16:16 America/New_York
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Iovance Biotherapeutics, Inc.
Read more...